Skip to main content
. 2017 Oct 3;2017(10):CD009839. doi: 10.1002/14651858.CD009839.pub2

Bassi 2015.

Methods RCT, prospective, randomised, open‐label
Participants 34 patients with symptomatic uncomplicated diverticular disease
Interventions 5‐ASA mesalazine 1.6 g/d or mesalazine 1.6 g/d + L. casei DG 16 billion/d for 10 days/month for 18 months
Outcomes 4 participants (11.8%) were symptom free after the 12th month of treatment.
Notes Both mesalazine and L. casei seem to be effective in preventing recurrence of uncomplicated symptomatic diverticular disease of the colon.